This article has Open Peer Review reports available.
Cognitive function at 2443 μmol/l creatinine
© Schneider et al.; licensee BioMed Central Ltd. 2012
Received: 3 April 2012
Accepted: 18 June 2012
Published: 15 August 2012
One hallmark of uremia is the impairment of neuro-cognitive function. Anecdotal clinical description from the early days of chronic dialysis therapy impressively illustrates the improvement of those functions by chronic hemodialysis treatment. Fortunately, today, uremia is only rarely observed in industrialized countries as many patients seek medical/nephrological attention prior to the occurrence of deadly complications of uremia.
We report a rare case of severe uremia and describe the day to day improvement in neuro-cognitive function by dialysis using state of the arte test battery – starting at a serum creatinine of 2443 μmol/l.
Especially executive functions, which are assumed to be localized in the frontal cerebral regions, are impaired in severe uremia and improve remarkably with the correction of severe uremia, i.e. initiation of dialysis.
KeywordsUremia Trail making A Executive function
In 1847 Piorry coined the term “uremia” describing a multi-facetted clinical syndrome consisting of digestive and neurological abnormalities secondary to renal failure and the resulting endogenous intoxication . One well documented finding in patients with chronic kidney disease (CKD) is the impairment of cognitive function. Kurella et al. could show that decreased eGFR (estimated glomerular filtration rate) in postmenopausal woman is associated significantly with impairment in global cognition, executive function, language, and memory . In a community-based cross-sectional study Elias et al. found that global performance and specific cognitive functions are negatively affected early in CKD . Interestingly not only a decrease in GFR but also elevated urinary albumin/creatinine ratios is independently associated with faster decline in cognitive function . Moreover, moderate renal impairment, has been shown to be associated with an excess risk of incident dementia among individuals in good to excellent health . The pathophysiological mechanism for this is still not clearly understood and range from urea to the endogenous NOS inhibitor ADMA [6, 7]. Moreover, there are no simple screening tools to diagnose cognitive function in CKD5D patients  While there is no doubt that severe uremia impairs cognitive function, the effect of a single dialysis session or dialysis intensity on cognitive impairment is controversially discussed. One study could not find any effect of a single dialysis on insensitive test like minimental state examination . Other authors reported that the removal of uremic toxins by hemodialysis lead to an improvement in cognitive processing . Also the potential effect of an increase of dialysis intensity on cognitive discussion is controversially discussed. While one pilot study in 12 patients showed improved general cognitive efficiency 6 months after switching from thrice weekly to nocturnal hemodialysis  results from the frequent hemodialysis network nocturnal trial showed no effect of increased dialysis intensity on cognitive performance, measured by Trail Making Test B only . We monitored the neuro-cognitive function of a patient with severe uremia in chronic humoral rejection secondary to non-adherence to immunosuppressive therapy after renal transplantation, starting at a serum creatinine of 2443 μmol/l.
A 27-year-old pale Caucasian male was admitted into the emergency room of our tertiary care hospital with the diagnosis of uremia. Upon arrival the overweight patient (BMI 32.7 kg/m²) had a blood pressure of 164/91 mmHg and a heart rate of 110/min. He presented with nausea and diarrhea, but was alert and awake. The remainder of the physical examination showed pericardial friction rub as well as a uremic foetor. His mucus membranes were dry and pale. His past medical history was significant for a living related kidney transplantation in 2008 for chronic interstitial nephritis and reflux nephropathy.
About ten weeks prior to the admission he stopped taking the immunosuppressive medication which consisted of tacrolimus, prednisolone and mycophenolat-mofetil. The main reason for discontinuation was allegedly his financial situation after a job loss, which did not allow him to pay the necessary co-payment for the immunosuppressive drugs. He did neither seek help from the hospital nor from the welfare authorities/social services. Laboratory analysis was remarkable for a serum creatinine of 2443 μmol/l a serum urea of 67.6 mmol/l and a serum phosphorous level of 2.69 mmol/l. His venous blood gas analysis showed a metabolic acidosis (pH 7.27, bicarbonate 14 mmol/l). He was anemic with a hemoglobin level of 6.9 g/dl.) Renal biopsy showed a severe irreversible damage of the graft due to chronic humural rejection. After transfer to our unit hemodialysis was initiated. The patient also received two units of packed red blood cells, which lead to an increase in hemoglobin level to 8.8 g/dl. Peak creatinine declined under the initiation of dialysis. Due to an ongoing research project on the evaluation of cognitive function in dialysis patients we were able to use a battery of established test for neuro-cognitive function for frequent monitoring. The patient consented to take part in frequent psychological tests consisting of computer-based attention tasks, memory tasks (short-term and long-term memory) and also several tasks to examine executive functions. The full test battery consisted of Wechsler Digit Span, Stories of Rivermead Behavioral Memory Test (RBMT), TMT A and B, Alertness and Go/NoGo subtest of Testbatterie zur Aufmerksamkeitsprüfung (TAP), Key Search and Zoo Map of Behavioral Assessment of the Dysexecutive Syndrome (BADS), Regensburger Wortflüssigkeitstest (RWT) as well as Rey Complex Figures.
The neuropsychological assessments were conducted by trained personal in a quiet environment. Tests were all performed between 08:00 and 10:00 AM to minimize the effect of circadian changes. To retain and optimize the patients´ compliance and motivation as well as to avert effects of interference between the several domains, the tests alternate in the order related to their verbal and visuo-constructive characteristic. Initial practice trails were administered for the following tests (TMT A, TMT B and TAP) to make sure that the task was understood by the patient. Tests with known training effects were not regularly repeated. The test battery with no or minimal influence by learning effects consisted of Wechsler Digit Span, Stories of RBMT, TMT A and B, Alertness and Go/NoGo subtest of TAP as well as Rey Complex Figures .
Raw scores and percentile of neuropsychological test battery
RAW SCORES (PERCENTILE)
test # 1
test # 2
test # 3
test # 4
test # 5
test # 6
Hospital day # TESTS
Story RBMT (words)
Rey Complex Figure
Immediate and delay
Wechsler Digit Span
Trail Making Test (seconds)
with acoustic signal
260 ± 57 (24)
226 ± 47 (38)
216 ± 30 (38)
273 ± 40 (12–14)
208 ± 27 (50)
200 ± 31 (73)
without acustic signal
279 ± 49 (10)
241 ± 34 (31)
233 ± 29 (38)
257 ± 39 (27)
225 ± 38(58)
207 ± 23 (73)
Laboratory parameters Serum Creatinin (μmol/l)
Serum Urea (mmol/l)
Calculated osmolality (mosmol/l)
The first report on the treatment of chronic uremia by intermittent hemodialysis by Scriber in 1960 identified already the main problems in treating CKD 5 D patients . Aside from anemia, sodium and fluid overload as well as hypertension Scribner et al. describe “increased fatigability, muscle cramps, irritability and lethargy” as symptoms of uremia. Sufficient intensity of dialysis in the first two chronic hemodialysis patients lead to a situation in which “neither patient has yet shown the relentless loss of weight and the mental deterioration which has been encountered in the past when less intensive dialysis therapy was employed”. This description epitomizes that at least some of the alterations in cognitive function in uremia are reversible in nature and could be due to the accumulation of uremic toxins. To our knowledge we report for the first time a sequential examination of a patient in severe uremia using an extensive state of the art battery of neurocognitive tests. A widespread armentarium has previously only been employed in a cross-sectional study of chronic hemodialysis patients . A study comparing the effect of acute removal of uremic toxins has to our knowledge so far not been conducted. Bae and Park compared Contingent Negative Variation (CNV) recorded with electroencephalogram 1 h before and 1 h after a dialysis session finding no significant difference . The neuropsychological tests (MMSE and TMT) they used were only for a cross-sectional analysis and not to compare pre- and post- dialysis cognitive status. Williams et al. studied patients at intervals of 1, 24, and 67 hours after the last weekly hemodialysis session and found fluctuations in memory and attention with a time dependent increase in impairment after the dialysis session .
The very nature of a case report does not allow generalizing the results we obtained in a peculiar case of uremia. Nonetheless we conclude that especially executive functions, which are assumed to be localized in the frontal cerebral regions, are impaired in severe uremia and improve remarkably with the initiation of dialysis treatment.
Written consent was obtained from the patient for publication of this study. Ethical approval was for reporting this case was obtained from the Medical School Hannover.
The publication of the study is supported by the DFG-project “Open Access Publication” at the Medical School Hannover.
- Richet G: Early history of uremia. Kidney Int. 1988, 33: 1013-1015. 10.1038/ki.1988.102.View ArticlePubMedGoogle Scholar
- Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM: Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005, 45: 66-76. 10.1053/j.ajkd.2004.08.044.View ArticlePubMedGoogle Scholar
- Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA: Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009, 24: 2446-2452. 10.1093/ndt/gfp107.View ArticlePubMedPubMed CentralGoogle Scholar
- Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J: Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol. 2012, 7: 437-443. 10.2215/CJN.05330611.View ArticlePubMedPubMed CentralGoogle Scholar
- Seliger SL, Siscovick DS, Stehman-Breen CO, Gillen DL, Fitzpatrick A, Bleyer A, Kuller LH: Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004, 15: 1904-1911. 10.1097/01.ASN.0000131529.60019.FA.View ArticlePubMedGoogle Scholar
- Kielstein JT, Kielstein A: ADMA and the brain: an unfolding story. Am J Hypertens. 2009, 22: 240-10.1038/ajh.2008.354.View ArticlePubMedGoogle Scholar
- Kielstein JT, Suntharalingam M, Perthel R, Rong S, Martens-Lobenhoffer J, Jager K, Bode-Boger SM, Nave H: Asymmetric dimethylarginine may mediate increased heat pain threshold in experimental chronic kidney disease. Nephrol Dial Transplant. 2012, 27: 899-902. 10.1093/ndt/gfr629.View ArticlePubMedGoogle Scholar
- Sorensen EP, Sarnak MJ, Tighiouart H, Scott T, Giang LM, Kirkpatrick B, Lou K, Weiner DE: The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis. 2012, 10.1053/j.ajkd.2011.12.029.Google Scholar
- Dahbour SS, Wahbeh AM, Hamdan MZ: Mini mental status examination (MMSE) in stable chronic renal failure patients on hemodialysis: The effects of hemodialysis on the MMSE score. A prospective study. Hemodial Int. 2009, 13: 80-85. 10.1111/j.1542-4758.2009.00343.x.View ArticlePubMedGoogle Scholar
- Madan P, Agarwal S, Kalra OP, Tandon OP: Effect of hemodialysis on cognitive function in ESRD patients. Ren Fail. 2007, 29: 699-703. 10.1080/08860220701460103.View ArticlePubMedGoogle Scholar
- Jassal SV, Devins GM, Chan CT, Bozanovic R, Rourke S: Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int. 2006, 70: 956-962. 10.1038/sj.ki.5001691.View ArticlePubMedGoogle Scholar
- Rocco MV, Lockridge RS, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S: The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011, 80: 1080-1091. 10.1038/ki.2011.213.View ArticlePubMedPubMed CentralGoogle Scholar
- Wagner S, Helmreich I, Dahmen N, Lieb K, Tadic A: Reliability of three alternate forms of the trail making tests a and B. Arch Clin Neuropsychol. 2011, 26: 314-321. 10.1093/arclin/acr024.View ArticlePubMedGoogle Scholar
- Bae JS, Park SS: Contingent negative variation before and after hemodialysis among patients with end-stage renal disease. J Neurol Sci. 2008, 267: 70-75. 10.1016/j.jns.2007.09.039.View ArticlePubMedGoogle Scholar
- Williams MA, Sklar AH, Burright RG, Donovick PJ: Temporal effects of dialysis on cognitive functioning in patients with ESRD. Am J Kidney Dis. 2004, 43: 705-711. 10.1053/j.ajkd.2003.12.031.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/13/86/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.